SESSION 1: Key United Nations High Level Meeting Declarations on TB and HIV. What’s next in the WHO European Region

Wednesday 15, May 2019, 9:00-12:30

1.1 WHO: Regional progress on implementing TB and HIV political declarations. Masoud Dara (English, Russian)

1.2 ECDC: Global targets for TB and HIV: Where are we in the European Union? Marieke van der Werf (English, Russian)

1.3 KNCV: Accelerating progress towards UNHLM targets in country: ensuring effective change management at a time of crucial innovations. Kitty van Weezenbeek (English, Russian)

1.4 Multisectoral accountability framework for TB and related HIV document(s).   Malgorzata Grzemska /Andrei Dadu (English, Russian)

1.5 Civil society experience with monitoring progress towards targets. Rachael Hore (English, Russian)

SESSION 2: Collaboration between TB and HIV programmes and partners

Wednesday 15, May 2019, 13:30 – 17:00

2.1 TB/HIV epidemiology in the WHO European region, concepts and frameworks on collaborative TB/HIV activities. Sayohat Hasanova (English, Russian)

2.2 Challenges in TB/HIV collaboration based on the survey of Wolfheze Working Group TB/HIV. Gerard de Vries (English, Russian)

2.3 Access to TB and HIV prevention, treatment and care services: patient and civil society  experience. Ala Iatco (English, Russian)

2.4 Achievements, gaps and challenges on sharing data and information between TB and HIV services (country perspective- Germany). Basel Karo (English, Russian)

Session 2 Group 1

Effective collaboration for integrated HIV-TB services ‘Belarus experience’ Alena Skrahina (English, Russian)

Effective collaboration for integrated HIV-TB services in Estonia. Piret Viiklepp (English, Russian)

Session 2 Group 2

TB screening and HIV – Swedish experience. Judith Bruchfeld (English, Russian)

Session 2 Group 3

Collaboration between TB and HIV programs, data management and report in Armenia. Anush Khachatryan (English, Russian)

Country perspective Germany. Basel Karo (English, Russian)

Session 3:

Country achievements on improving TB prevention and care

Thursday 16, May 2019, 9:00- 10:30

3,1 New European LTBI guidelines. Martin van den Boom and Senia Rosales-Klintz (English, Russian)

3.2 Reduction of tuberculosis transmission. G.B. Migliori (English, Russian)

3.3 Country achievements towards TB Elimination: experiences from the Republic of Moldova. Valentina Vilc (English, Russian)

Session 3 Group 2

Country achievements on improving TB prevention and care.  Reducing the risk of TB transmission Puck Pelzer (English, Russian)

Session 3 Group 3

TB prevention in vulnerable populations in low burden countries. Alberto Matteelli (English, Russian)


RESEARCH. European Perspective

Thursday 16, May 2019, 11:00-12:30

4.1 WHO Global strategy for TB Research and innovation and its operationalization at the Regional level (European TB research priorities). Andrei Dadu. (English)

4.2 Structured Operational Research and Training of the European TB research Initiative (SORT-TB): building capacity and catalyzing research agenda implementation. Olexander Korotich (English)

4.3 Belarus: Prevalence and determinants associated with treatment outcomes in M/XDR pulmonary TB with Bedaquiline containing regimens (2013 – 2016). Dmitry Zhurkin (English)

4.4 The Netherlands: Tuberculin skin test reaction highly depends on purified protein derivative: implications for cut-off values. Christiaan Mulder (English, Russian)

4.5 Panel discussion:  Taking research into practice: what does it take? dine Tiemersma (English, Russian)

Session: 5:

What is new in MDR-/ RR-TB management treatment policies and guidelines

Thursday 16, May 2019, 13:30- 17:00

5.1 WHO recommendations on DR-TB management – guidelines 2018 and companion guide. Ernesto Jaramillo (English, Russian)

5.2 Debriefing from GLC Euro meeting in Vienna. Ogtay Gozalov (English, Russian)

5.3 Aligning diagnostics and treatment – WHO updates on genome sequencing. Andrea Maurizio Cabibbe (English, Russian)

5.4 Experience and future role of genome sequencing in Kyrgyzstan. Gulmira Kalmambetova (English, Russian)

Session 5 Group 1 (Procurement)      

Procurement supply chain management – updates from GDF in light of new guidelines. Maya Kavtaradze (English, Russian)

Session 5 Group 1

Efficient drug management as a result of high-level political support, Estonia. Piret Viiklepp (English, Russian)

Session 5 Group 2 (aDSM):     

Progress and required changes in treatment safety monitoring. GB Migliori (English, Russian)

Treatment safety monitoring, experience from Kazakhstan. Kagaz Serikbaeva (English, Russian)

Group 3 (Children): 

Updates on MDR management in children (WHO recommendations, Sentinel guide) Gunta Dravniece (English, Russian)

Use of new drugs for children with DR-TB. Alena Skrahina (English, Russian)

5.5 Building platforms for rapid countrywide adoption of innovations, experience from Kyrgyzstan. Abdullat Kadyrov (English, Russian)

5.6 Reports from groups – main gaps, way forward (English, Russian)

Session 6:

Countering stigma and achieving people- centered TB care.

Friday 17, May 2019, 9:00- 12:00

6.1 Kazakhstan Building Models for the Future project non-public sector engagement to improve people- centered care & access to quality TB/HIV prevention & care. Tanya Pushkina,  Kristina Zhorayeva (English, Russian)

6.2 Reducing stigma we get closer to Ending TB. Sholpanata Kaldarov  Amanzhan Abubakirov (English, Russian)

6.3 The role of digital health tools in achieving delivery of people – centered quality care. Egwuma Efo  (English, Russian)

6.4. WG-PCC report on available reports and tools regarding People-Centred Care in our Region. Jagjit Dosanjh-Elton (English, Russian)

6.5 WG-PCC Questionnaire feedback on barriers and solutions to PCC as seen by national programmes and civil society organizations. Niesje Jansen (English, Russian)

Session 7:


Friday 17, May 2019, 12:00- 13:00

7.1 Wolfheze Workshops: Next steps. Way forward 7.1  Masoud Dara, Kitty van Weezenbeek  (English)